Sands Capital Management 13F holdings, Q1 2010
Holdings as of March 31, 2010 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 45 US equity positions worth $11.5bn in its Q1 2010 13F filing. The largest position was AAPL at 8.8% of the reported book, followed by AMZN and GOOGLE. Against the Q4 2009 filing, it opened 2 new positions, added to 4 and reduced 36 among the top 45 holdings.
What did Sands Capital Management own in Q1 2010? Top 45 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2009 |
|---|---|---|---|---|---|---|---|
| 1 | AAPL APPLE | Technology | 8.8% | $1.0bn | 4,329,159 | -4% | reduced |
| 2 | AMZN AMAZON.COM | Consumer Cyclical | 8.1% | $937.2m | 6,902,877 | -4% | reduced |
| 3 | 6.4% | $737.4m | 1,300,327 | -5% | reduced | ||
| 4 | V VISA INC | Financial Services | 6.0% | $693.8m | 7,621,641 | -5% | reduced |
| 5 | ALLERGAN | 5.4% | $624.6m | 9,562,306 | -6% | reduced | |
| 6 | NATIONAL OILWELL VARCO | 5.4% | $619.1m | 15,256,694 | -4% | reduced | |
| 7 | CRM SALESFORCE.COM | Technology | 5.4% | $617.4m | 8,292,276 | -4% | reduced |
| 8 | QCOM QUALCOMM | Technology | 5.1% | $584.0m | 13,918,407 | -4% | reduced |
| 9 | GENZYME | 4.7% | $537.1m | 10,363,230 | -7% | reduced | |
| 10 | SLB SCHLUMBERGER | Energy | 4.6% | $529.6m | 8,346,103 | -4% | reduced |
| 11 | FMC TECHNOLOGIES | 4.6% | $525.5m | 8,130,809 | -5% | reduced | |
| 12 | INTERCONTINENTAL EXCHANGE | 4.3% | $492.2m | 4,387,224 | -6% | reduced | |
| 13 | MONSANTO | 3.7% | $421.6m | 5,902,932 | -6% | reduced | |
| 14 | NKE NIKE | Consumer Cyclical | 3.5% | $405.8m | 5,520,695 | 15% | added |
| 15 | SCHW CHARLES SCHWAB | Financial Services | 3.3% | $376.0m | 20,120,168 | 118% | added |
| 16 | ILMN ILLUMINA INC | Healthcare | 3.2% | $366.1m | 9,410,807 | 46% | added |
| 17 | VARIAN MEDICAL SYSTEMS | 3.0% | $347.4m | 6,279,472 | -7% | reduced | |
| 18 | LVS LAS VEGAS SANDS | Consumer Cyclical | 2.9% | $333.4m | 15,765,420 | -4% | reduced |
| 19 | CME CME GROUP | Financial Services | 2.4% | $277.3m | 877,376 | -5% | reduced |
| 20 | AVGO BROADCOM | Technology | 2.2% | $257.9m | 7,769,347 | -4% | reduced |
| 21 | STAPLES | 1.9% | $218.1m | 9,314,383 | -5% | reduced | |
| 22 | GWW WW GRAINGER INC | Industrials | 1.7% | $198.5m | 1,835,778 | – | new |
| 23 | FLIR FLIR SYSTEMS INC | 1.5% | $171.5m | 6,086,309 | -5% | reduced | |
| 24 | IRON MOUNTAIN | 1.2% | $136.0m | 4,962,303 | -5% | reduced | |
| 25 | MINDRAY MEDICAL INTL | 0.3% | $36.3m | 995,925 | -11% | reduced | |
| 26 | MELI MERCADOLIBRE | Consumer Cyclical | 0.2% | $26.2m | 543,700 | -0% | held |
| 27 | ABBNY ABB LTD | Industrials | 0.2% | $23.6m | 1,079,650 | -0% | held |
| 28 | NUVASIVE | 0.0% | $1.5m | 33,575 | -72% | reduced | |
| 29 | TSM TAIWAN SEMICONDUCTOR MFG ADS | Technology | 0.0% | $1.3m | 124,700 | 6% | added |
| 30 | BMRN BIOMARIN PHARMS | Healthcare | 0.0% | $1.3m | 55,200 | -78% | reduced |
| 31 | CELG CELGENE | 0.0% | $1.1m | 17,150 | -78% | reduced | |
| 32 | SYK STRYKER | Healthcare | 0.0% | $953.0k | 16,650 | -99% | reduced |
| 33 | ST. JUDE MEDICAL | 0.0% | $944.0k | 23,000 | -78% | reduced | |
| 34 | DENTSPLY INTL | 0.0% | $921.0k | 26,400 | -71% | reduced | |
| 35 | GILD GILEAD SCIENCES | Healthcare | 0.0% | $873.0k | 19,200 | -78% | reduced |
| 36 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 0.0% | $846.0k | 8,560 | -78% | reduced |
| 37 | HUMAN GENOME SCIENCES | 0.0% | $646.0k | 21,400 | -78% | reduced | |
| 38 | VRTX VERTEX PHARMS | Healthcare | 0.0% | $575.0k | 14,075 | -83% | reduced |
| 39 | MYGN MYRIAD GENETICS | Healthcare | 0.0% | $548.0k | 22,800 | -78% | reduced |
| 40 | ATHENAHEALTH, INC | 0.0% | $506.0k | 13,850 | – | new | |
| 41 | ISIS PHARMACEUTICAL | 0.0% | $389.0k | 35,600 | -78% | reduced | |
| 42 | SEATTLE GENETICS INC | 0.0% | $375.0k | 31,400 | -78% | reduced | |
| 43 | CSCO CISCO SYSTEMS | Technology | 0.0% | $364.0k | 14,000 | 0% | held |
| 44 | ALNY ALNYLAM PHARMS | Healthcare | 0.0% | $352.0k | 20,675 | -78% | reduced |
| 45 | VIVUS INC | 0.0% | $344.0k | 39,400 | -78% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.